Toselli Richard M. 4
4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Dec 20, 2018
Insider Transaction Report
Form 4
Toselli Richard M.
Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2018-12-18$1.69/sh−961$1,624→ 11,039 total - Award
Common Stock
2018-12-18+12,000→ 12,000 total
Footnotes (2)
- [F1]3,000 shares representing the one-for-one conversion of restricted stock units ("RSUs") vested on December 18, 2018. Subject to Dr. Toselli's continued employment with the Company, the remaining 9,000 shares will vest in equal monthly installments until fully vested on December 18, 2021.
- [F2]Represents shares sold by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2018 to satisfy tax withholding obligations applicable to the vesting of 3,000 stock-settled RSUs referenced in Footnote 1.